# Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

> **NCT06485336** · PHASE2 · RECRUITING · sponsor: **St. Olavs Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Chronic Migraine

## Interventions

- **DRUG:** Atorvastatin 40mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06485336
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-02-28
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-07-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06485336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06485336, "Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06485336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*